Literature DB >> 9001242

Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.

B C Schaefer1, E Paulson, J L Strominger, S H Speck.   

Abstract

The Epstein-Barr virus (EBV) EBNA1 gene promoter active in the type I program of restricted viral latency was recently identified and shown to reside in the viral BamHI Q fragment. This promoter, Qp, is active in a wide variety of cell lines and has an architecture reminiscent of eukaryotic housekeeping gene promoters (B. C. Schaefer, J. L. Strominger, and S. H. Speck, Proc. Natl. Acad. Sci. USA 92:10565-10569, 1995; B. C. Schaefer, J. L. Strominger, and S. H. Speck, Mol. Cell. Biol. 17:364-377, 1997). Here we demonstrate by deletion analysis that the important cis-acting elements regulating Qp are clustered in a relatively small region (ca. 80 bp) surrounding the site of transcription initiation. Immediately upstream of the site of initiation is a region which is protected from DNase I digestion by crude nuclear extracts. Electrophoretic mobility shift analyses (EMSA) employing probes spanning this region demonstrated the presence of two major protein complexes. Deletion analysis of Qp demonstrated that at least one of these complexes plays an important role in Qp activity. Evidence that interferon response factor 2 (IRF2) is a major constituent of the most prominent EMSA complex and that IRF1 may be a minor component of this complex is presented. Transfections into IRF1-/-, IRF2-/-, and IRF1,2-/- fibroblasts demonstrated that absence of both IRF1 and IRF2 reduced Qp activity to approximately the same extent as mutation of the IRF-binding site in Qp, strongly implicating IRF2, and perhaps IRF1, in the regulation of Qp activity. Notably, transcription from Qp was not inducible by either alpha or gamma interferon in EBV-negative B cells but rather was shown to be constitutively activated by IRF1 and IRF2. This observation suggests that IRF1 and IRF2 have a previously unrecognized role as constitutive activators of specific genes. Additionally, data presented indicate that a protein complex containing the nonhistone architectural protein HMG-I(Y) binds to the region identified as the major transcription initiation site for Qp. This observation raises the possibility that HMG-I(Y)-induced DNA bending plays a role in the initiation of transcription from Qp.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9001242      PMCID: PMC231814          DOI: 10.1128/MCB.17.2.873

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  97 in total

1.  The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.

Authors:  B C Schaefer; J L Strominger; S H Speck
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

2.  Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.

Authors:  N S Sung; J Wilson; M Davenport; N D Sista; J S Pagano
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

Review 3.  Epstein-Barr virus strategy in normal and neoplastic B cells.

Authors:  G Klein
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

4.  The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level.

Authors:  A Weiss; R L Wiskocil; J D Stobo
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

5.  Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family.

Authors:  C Bovolenta; P H Driggers; M S Marks; J A Medin; A D Politis; S N Vogel; D E Levy; K Sakaguchi; E Appella; J E Coligan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms.

Authors:  W Du; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

8.  Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter.

Authors:  E Neuman; E K Flemington; W R Sellers; W G Kaelin
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

9.  Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

Authors:  N Tanaka; M Ishihara; M Kitagawa; H Harada; T Kimura; T Matsuyama; M S Lamphier; S Aizawa; T W Mak; T Taniguchi
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

10.  Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression.

Authors:  S A Abdulkadir; S Krishna; D Thanos; T Maniatis; J L Strominger; S J Ono
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  32 in total

1.  The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.

Authors:  H Chen; J M Lee; Y Wang; D P Huang; R F Ambinder; S D Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

Authors:  M G Davenport; J S Pagano
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.

Authors:  L Zhang; J S Pagano
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  B Cell-Intrinsic Expression of Interferon Regulatory Factor 1 Supports Chronic Murine Gammaherpesvirus 68 Infection.

Authors:  C N Jondle; K E Johnson; A A Uitenbroek; P A Sylvester; C Nguyen; W Cui; V L Tarakanova
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

6.  The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells.

Authors:  Timothy R Geiger; Jennifer M Martin
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

7.  IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency.

Authors:  L Zhang; J S Pagano
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 8.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

9.  High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.

Authors:  Agnes Bakos; Ferenc Banati; Anita Koroknai; Maria Takacs; Daniel Salamon; Susanna Minarovits-Kormuta; Fritz Schwarzmann; Hans Wolf; Hans Helmut Niller; Janos Minarovits
Journal:  Virus Genes       Date:  2007-05-18       Impact factor: 2.332

10.  An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression.

Authors:  V Kiermer; C Van Lint; D Briclet; C Vanhulle; R Kettmann; E Verdin; A Burny; L Droogmans
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.